切换至 "中华医学电子期刊资源库"

中华医学超声杂志(电子版) ›› 2022, Vol. 19 ›› Issue (09) : 1016 -1019. doi: 10.3877/cma.j.issn.1672-6448.2022.09.026

病例报告

克罗恩病合并肉芽肿性肝炎三例
陈秋1, 覃斯1, 崔瑞1, 程文捷1, 刘广健1,()   
  1. 1. 510655 广州,中山大学附属第六医院超声科/广东省结直肠盆底疾病研究重点实验室
  • 收稿日期:2020-09-18 出版日期:2022-09-01
  • 通信作者: 刘广健

Crohn's disease complicated with granulomatous hepatitis: report of three cases

Qiu Chen1, Si Qin1, Rui Cui1   

  • Received:2020-09-18 Published:2022-09-01
引用本文:

陈秋, 覃斯, 崔瑞, 程文捷, 刘广健. 克罗恩病合并肉芽肿性肝炎三例[J]. 中华医学超声杂志(电子版), 2022, 19(09): 1016-1019.

Qiu Chen, Si Qin, Rui Cui. Crohn's disease complicated with granulomatous hepatitis: report of three cases[J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2022, 19(09): 1016-1019.

表1 3例克罗恩病合并肉芽肿性肝炎患者实验室检测结果
图1 3例克罗恩病患者CT小肠造影动脉期显示多个肝结节。病例1(图a~d):肝内共见4个结节,在动脉期呈环状高增强(箭头);病例2(图e~h):肝内共见4个结节,在动脉期呈不均匀稍高增强(箭头);病例3(图i~k):肝内共见3个结节,在动脉期呈环状高增强(箭头)
图2 3例克罗恩病患者肝占位病变的CT小肠造影强化模式及随访图像。病例1(图a~d):图a CT平扫病变呈等密度,边界不清楚(箭头);图b动脉期病变呈环状高增强(箭头);图c门静脉期病变呈稍低/等增强(箭头);图d治疗后复查,动脉期显示肝内原病灶消失。病例2(图e~h):图e CT平扫病变呈等密度,边界不清楚(箭头);图f动脉期病变呈不均匀稍高增强(箭头);图g门静脉期病变呈等增强(箭头);图h治疗后复查,动脉期显示肝内原病灶消失。病例3(图i~k):图i CT平扫病变呈等密度,边界不清楚(箭头);图j动脉期病变呈环状高增强(箭头);图k门静脉期病变呈等增强(箭头)
图3 病例1和病例2肝内病灶的MRI图像。病例1(图a~f):图a病变在T1加权成像呈等信号,边界不清楚(箭头);图b T2加权成像呈高信号(箭头);图c动脉期呈稍高增强(箭头);图d静脉期渐进性强化(箭头);图e延迟期持续强化(箭头);图f 弥散加权成像呈高信号(箭头)。病例2(图g~l):图g病变在T1加权成像呈等信号,边界不清楚(箭头);图h T2加权成像呈高信号(箭头);图i动脉期呈稍高增强(箭头);图j静脉期渐进性强化(箭头);图k延迟期持续强化(箭头);图l 弥散加权成像呈高信号(箭头)
图4 3例克罗恩病患者肝结节的超声造影图像。病例1(图a~d):图a二维超声为稍低回声结节,边界不清(箭头);图b动脉期,在14 s结节开始强化呈稍高增强(箭头);图c门期期,在36 s肝结节消退呈稍低增强(箭头);图d延迟期肝结节呈低增强(箭头)。病例2(图e~h):图e二维超声为稍低回声结节,边界不清(箭头);图f动脉期,肝结节在14 s开始强化呈稍高增强(箭头);图g门期期,肝结节在36 s消退呈稍低增强(箭头);图h延迟期肝结节呈低增强(箭头)。病例3(图i~l):图i二维超声为稍低回声结节,边界不清(箭头);图j动脉期,在14 s结节开始强化呈稍高增强(箭头);图k门期期,在36 s肝结节消退呈稍低增强(箭头);图l延迟期肝结节呈低增强(箭头)
图5 3例克罗恩病患者的病理切片(HE×400)。图a病例1:肝组织内见多个上皮样肉芽肿,未见干酪样坏死,病变符合肝肉芽肿性肝炎。图b病例2:肝组织内见多个上皮样肉芽肿,病变符合肝肉芽肿性肝炎,特殊染色:TB(-)。图c病例3:肝组织见非干酪样肉芽肿,免疫组织化学:CD68组织细胞(+)
1
Fousekis FS, Theopistos VI, Katsanos KH, et al. Hepatobiliary manifestations and complications in inflammatory bowel disease: a review [J]. Gastroenterology Res, 2018, 11(2): 83-94.
2
Iqbal U, Siddiqui HU, Anwar H, et al. Allopurinol-induced granulomatous hepatitis: a case report and review of literature [J]. J Investig Med High Impact Case Rep, 2017, 5(3): 1561909534.
3
Braun M, Fraser GM, Kunin M, et al. Mesalamine-induced granulomatous hepatitis [J]. Am J Gastroenterol, 1999, 94(7): 1973-1974.
4
Barrera L, Alvarez J, Tapias M, et al. Granulomatous hepatitis secondary to histoplasma infection after treatment with infliximab [J]. Case Reports Hepatol, 2013, 2013: 807537.
5
Flamm SL. Granulomatous liver disease [J]. Clin Liver Dis, 2012, 16(2): 387-396.
6
Restellini S, Chazouillères O, Frossard J. Hepatic manifestations of inflammatory bowel diseases [J]. Liver Int, 2017, 37(4): 475-489.
7
Jo PC, Jang HJ, Burns PN, et al. Integration of contrast-enhanced US into a multimodality approach to imaging of nodules in a cirrhotic liver: how i do it [J]. Radiology, 2017, 282(2): 317-331.
8
Liu GJ, Lu MD, Xie XY, et al. Real-time contrast-enhanced ultrasound imaging of infected focal liver lesions [J]. J Ultrasound Med, 2008, 27(4): 657-666.
9
Kunze G, Staritz M, Kohler M. Contrast-enhanced ultrasound in different stages of pyogenic liver abscess [J]. Ultrasound Med Biol, 2015, 41(4): 952-959.
No related articles found!
阅读次数
全文


摘要